UMIN ID: UMIN000002213
Registered date:26/07/2009
Phase two clinical trial of limited stage lymphoblastic lymphoma.
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Limited stage lymphoblastic lymphoma |
| Date of first enrollment | 2005/02/01 |
| Target sample size | 42 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Treatment regimen has fundamentally BFM backbone with reinduction phase |
Outcome(s)
| Primary Outcome | 3 year event-free survival |
|---|---|
| Secondary Outcome | (1) 3year overall survival (2)Incidence of therapy-rerated severe toxicity |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 18years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1, Down's syndrome 2, previous malignancy of any type 3, Prior stem cell or organ transplantation 4, Congenital or acquired immunodeficiency |
Related Information
| Primary Sponsor | Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG) |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Ministry of Health, Labour and Welfare |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shosuke Sunami |
| Address | 90-1 Iidacho Narita city Japan Japan |
| Telephone | 0476221311 |
| s-sunami@sc4.so-net.ne.jp | |
| Affiliation | Japanese Red Cross Narita Hospital Department of Pediatrics |
| scientific contact | |
| Name | Shosuke Sunami |
| Address | 90-1 Iidacho Narita city Japan Japan |
| Telephone | 0476222311 |
| s-sunami@sc4.so-net.ne.jp | |
| Affiliation | Japanese Red Cross Narita Hospital Department of Pediatrics |